|国家科技期刊平台
首页|期刊导航|环境与职业医学|草氨酸钠通过抑制肺泡Ⅱ型上皮细胞衰老减轻小鼠矽肺纤维化

草氨酸钠通过抑制肺泡Ⅱ型上皮细胞衰老减轻小鼠矽肺纤维化OA北大核心CSTPCD

Oxamate alleviates silicotic fibrosis in mice by inhibiting senescence of alveolar type Ⅱ epithelial cells

中文摘要英文摘要

[背景]肺泡Ⅱ型上皮细胞衰老是矽肺纤维化进展的重要驱动因素,草氨酸钠对肺泡Ⅱ型上皮细胞衰老的调节作用尚不清楚. [目的]探讨乳酸脱氢酶抑制剂草氨酸钠是否可通过抑制肺泡Ⅱ型上皮细胞衰老减轻小鼠矽肺纤维化. [方法]本研究分为体内实验和体外实验两部分.体内研究中将40只SPF级雄性C57BL/6J随机分为 4组,每组 10只,实验分组为对照组、矽肺模型组、草氨酸钠低剂量治疗组、草氨酸钠高剂量治疗组.采用一次性气管灌注SiO2 悬浊液 50 μL(100 mg·mL-1)制备矽肺小鼠模型;采用腹腔注射草氨酸钠 100 μL(225 mmol·L-1 和 1125 mmol·L-1)制备草氨酸钠治疗模型.体外研究中采用SiO2 诱导MLE-12小鼠肺泡Ⅱ型上皮细胞,实验分组为①不同浓度SiO2 诱导组:对照组、50 μg·mL-1 SiO2 组、100 μg·mL-1 SiO2 组和 200 μg·mL-1 SiO2 组;②草氨酸钠治疗组:对照组、SiO2 组(100 μg·mL-1)、草氨酸钠低剂量(25 mmol·L-1)治疗组和草氨酸钠高剂量(50 mmol·L-1)治疗组.采用苏木素-伊红(HE)染色观察肺组织病理学形态;天狼星红染色观察肺组织胶原蛋白沉积;采用免疫荧光染色观察表面活性蛋白C前体(Pro-SPC)和β-半乳糖苷酶(β-galactosidase)的阳性共表达;采用免疫荧光染色观察MLE-12细胞β-galactosidase的阳性表达;采用免疫印迹法检测Ⅰ型胶原(CoL Ⅰ)、纤维连接蛋白 1(FN1)、己糖激酶 2(HK2)、肌肉丙酮酸激酶同工酶 2(PKM2)、乳酸脱氢酶A(LDHA)、磷酸化毛细血管扩张性共济失调(p-ATR)、细胞周期蛋白依靠性激酶抑制剂p21和p16的蛋白表达水平. [结果]与对照组相比较,矽肺模型组和 SiO2 诱导的 MLE-12细胞中,HK2、PKM2、LDHA、p-ATR、p21和p16的蛋白表达水平均上调(P<0.05).体内研究显示,与对照组相比较,矽肺模型组中,矽结节面积,胶原蛋白沉积面积,β-galactosidase阳性细胞数占比,CoL Ⅰ、FN1、LD-HA、p-ATR、p21和p16的蛋白表达水平均上调(P<0.05);与矽肺模型组相比较,草氨酸钠治疗组中矽结节面积,胶原蛋白沉积面积,β-galactosidase阳性细胞数占比,CoL Ⅰ、FN1、LDHA、p-ATR、p21和p16的蛋白表达水平均下调,且草氨酸钠高剂量治疗组效果优于草氨酸钠低剂量治疗组(P<0.05).体外研究显示,与对照组相比较,SiO2 诱导组中,β-galactosidase阳性细胞数占比、p-ATR、p21和p16的蛋白表达水平均上调(P<0.05);与SiO2 组相比较,草氨酸钠治疗组中β-galactosidase阳性细胞数占比、LDHA、p-ATR、p21和p16的蛋白表达水平均下调,且草氨酸钠高剂量治疗组效果优于草氨酸钠低剂量治疗组(P<0.05). [结论]乳酸脱氢酶抑制剂草氨酸钠可通过抑制肺泡Ⅱ型上皮细胞衰老以减轻小鼠矽肺纤维化.

[Background]The senescence of alveolar type Ⅱ epithelial cells is an important driving factor for the progression of silicotic fibrosis,and the regulatory effects of oxamate on the senescence of alveolar type Ⅱ epithelial cells is still unclear. [Objective]To explore whether lactate dehydrogenase inhibitor oxamate can alleviate silicotic fibrosis in mice by inhibiting senescence of alveolar type Ⅱ epithelial cells [Methods]This study was divided into two parts:in vivo experiments and in vitro experiments.In the first part,forty SPF C57BL/6J male mice were randomly divided into four groups with 10 in each group:control group,silicosis model group,low-dose oxamate treatment group,and high-dose oxamate treatment group.The silicotic mouse model was established by intratracheal instillation of 50 μL SiO2 sus-pension(100 mg·mL-1).The treatment models were prepared by intraperitoneal injection of 100 μL oxamate(225 mmol·L-1 and 1125 mmol·L-1).In the second part,induction of MLE-12 mouse alveolar type Ⅱ epithelial cells was conducted with SiO2.The in vitro experimental groups were ① SiO2 induction groups:control group,50 μg·mL-1 SiO2 group,100 μg·mL-1 SiO2 group,and 200 μg·mL-1 SiO2 group,and ②oxamate treatment groups:control group,SiO2 group(100 μg·mL-1),low-dose oxamate(25 mmol·L-1)treatment group,and high-dose oxamate(50 mmol·L-1)treatment group.Pathological morphology of lung tissues was evaluated after hematoxylin-eosin(HE)staining;deposition of collagen in lung tissues was evaluated after sirius red staining;positive co-expression of prosurfactant protein C(Pro-SPC)and β-galactosidase was detected by immunofluorescence staining;positive expression of β-galactosidase in MLE-12 cells was detected by immunofluorescence staining.The protein expression levels of collagen type Ⅰ(CoL Ⅰ),fibronectin1(FN1),hexokinase 2(HK2),pyruvate kinase isozyme type M2(PKM2),lactate dehydrogenase A(LDHA),p-ataxia telangiectasia and Rad3-related kinase(ATR),and cyclin-de-pendent kinase inhibitors p21,and p16 were detected by Western blotting. [Results]Compared with the control group,the protein expression levels of HK2,PKM2,LDHA,p-ATR,p21,and p16 were significantly up-regulated in the silicosis model group and the SiO2-induced MLE-12 cells(P<0.05).The in vivo studies showed that,compared with the control group,the silicon nodule area,the collagen deposition area,the proportion of β-galactosidase positive cells,and the protein ex-pression levels of CoL I,FN1,LDHA,p-ATR,p21,and p16 were significantly upregulated in the silicosis model group(P<0.05).Compared with the silicosis model group,the oxamate treatment groups showed significant downregulation of the silicon nodule area,the collagen deposition area,the proportion of β-galactosidase positive cells,and the the CoL I,FN1,LDHA,p-ATR,p21,and p16 protein expression levels,and the high-dose oxamate treatment group showed a higher efficacy on these indicators than the low-dose oxamate treatment group(P<0.05).The in vitro studies showed that,compared with the control group,the proportion of β-galactosidase positive cells and the protein expression levels of p-ATR,p21,and p16 were significantly upregulated in the SiO2-induced group(P<0.05).Compared with the SiO2 group,the proportion of β-galactosidase positive cells and the LDHA,p-ATR,p21 and p16 protein expression levels were significantly downregulated in the oxamate treatment groups,and the high-dose oxamate treatment group showed a higher efficacy on these indicators than the low-dose oxamate treatment group(P<0.05). [Conclusion]Lactate dehydrogenase inhibitor oxamate can alleviate silicotic fibrosis in mice by inhibiting the senescence of alveolar type Ⅱ epithelial cells.

刘文静;毛娜;李雅倩;高学敏;魏中秋;朱莹;徐洪;靳馥宇

华北理工大学公共卫生学院,河北唐山 063200华北理工大学基础医学院,河北唐山 063200华北理工大学公共卫生学院,河北唐山 063200||华北理工大学医学部,河北唐山 063200

预防医学

草氨酸钠肺泡Ⅱ型上皮细胞矽肺衰老β-半乳糖苷酶

oxamatealveolar type Ⅱ epithelial cellsilicosissenescenceβ-galactosidase

《环境与职业医学》 2024 (007)

760-767,779 / 9

国家自然科学基金项目(82204006);河北省自然科学基金项目(H2021209049);河北省高等学校科学技术研究项目(QN2022009);华北理工大学2022年度教育教学改革研究与实践项目(ZJ2211)

10.11836/JEOM24018

评论